Dowzone Pharm to sell chewable glucose tablet

Published: 2004-07-28 06:56:00

Updated: 2004-07-28 06:56:00

Dowzone Pharm, a local biopharmaceutical firm, unveiled its plan to launch a chewable glucose tablet form 'SOLLUS' in the domestic pharmacy market next month. Its active ingredients include glucose (95%), herbal extracts, various vitamins, taurine, calcium and magnesium.

SOLLUS, which was pro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK